Clinical Trial Update: Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention. [Phase 3]

View source ↗

Summary

Phase 3 trial results for a fixed-dose combination polypill for secondary cardiovascular prevention after myocardial infarction have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Polypill

Snippet

Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III | Conditions: Myocardial Infarction | Phase 3 | Status: COMPLETED